Marco Pizzoferrato
Overview
Explore the profile of Marco Pizzoferrato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
538
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Covello C, Becherucci G, Di Vincenzo F, Del Gaudio A, Pizzoferrato M, Cammarota G, et al.
Nutrients
. 2024 Jul;
16(14).
PMID: 39064731
Malnutrition poses a critical challenge in inflammatory bowel disease, with the potential to detrimentally impact medical treatment, surgical outcomes, and general well-being. Parenteral nutrition is crucial in certain clinical scenarios,...
2.
Covello C, Di Vincenzo F, Cammarota G, Pizzoferrato M
Curr Issues Mol Biol
. 2024 Mar;
46(3):2658-2677.
PMID: 38534784
Microplastics and nanoplastics (MNPs) are becoming an increasingly severe global problem due to their widespread distribution and complex impact on living organisms. Apart from their environmental impact, the effects of...
3.
Parisio L, Settanni C, Varca S, Laterza L, Lopetuso L, Napolitano D, et al.
J Gastrointestin Liver Dis
. 2023 Dec;
32(4):452-459.
PMID: 38147610
Background And Aims: Subcutaneous vedolizumab formulation has been shown to be as effective and safe as the intravenous one in randomized control trials. Real-life data are limited especially for patients...
4.
Di Vincenzo F, Ennas S, Pizzoferrato M, Bibbo S, Porcari S, Ianiro G, et al.
Intern Emerg Med
. 2023 Jul;
19(1):13-37.
PMID: 37500944
Background: Henoch-Schonlein purpura (HSP) is an IgA-mediated systemic small-vessel vasculitis (IgAV) that typically presents with a variable tetrad of symptoms. HSP if often preceded by respiratory tract infections, vaccinations, drugs...
5.
Pizzoferrato M, Puca P, Ennas S, Cammarota G, Guidi L
World J Gastroenterol
. 2022 Dec;
28(44):6258-6270.
PMID: 36504557
Short bowel syndrome (SBS) with intestinal failure (IF) is a rare but severe complication of Crohn's disease (CD), which is the most frequent benign condition that leads to SBS after...
6.
Del Vecchio L, Fiorani M, Tohumcu E, Bibbo S, Porcari S, Mele M, et al.
Microorganisms
. 2022 Jul;
10(7).
PMID: 35889034
infection (CDI) and inflammatory bowel disease (IBD) are two pathologies that share a bidirectional causal nexus, as CDI is known to have an aggravating effect on IBD and IBD is...
7.
Graziani C, Laterza L, Talocco C, Pizzoferrato M, Di Simone N, DIppolito S, et al.
J Pers Med
. 2022 Jun;
12(6).
PMID: 35743789
Recurrent cystitis (RC) is a common disease, especially in females. Anatomical, behavioral and genetic predisposing factors are associated with the ascending retrograde route, which often causes bladder infections. RC seems...
8.
Papa A, Scaldaferri F, Covino M, Tursi A, Furfaro F, Mocci G, et al.
Biomedicines
. 2022 Apr;
10(4).
PMID: 35453593
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has raised concerns in patients with inflammatory bowel disease (IBD), not only due to consequences of coronavirus disease 2019 itself but also...
9.
Tursi A, Mocci G, Allegretta L, Aragona G, Bianco M, Colucci R, et al.
Expert Opin Biol Ther
. 2021 Dec;
22(2):313-320.
PMID: 34904510
Background: To compare the performances of Infliximab (IFX) biosimilar CT-P13 and SB2 in the treatment of Inflammatory Bowel Diseases (IBD) outpatients in Italy. Research Design And Methods: Three hundred and...
10.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso L, Rizzatti G, et al.
United European Gastroenterol J
. 2020 May;
8(7):775-781.
PMID: 32438878
The coronavirus disease 2019 (COVID-19) pandemic is having a major clinical as well as organisational impact on the national health-care system in Italy, particularly in high-volume hospitals which are usually...